The 6th annual Epigenetics Symposium will be held Thursday, October 13th, 2022. The day will include a keynote seminar and a series of short talks from UW Epigenetics faculty. Trainee oral presentations will be selected from abstracts. The talks will be held at Union South Varsity Hall, and the PM poster session and social will be across the street at the Discovery Building.
Qiang Chang, a longstanding member of the University of Wisconsin–Madison Waisman Center’s leadership team, has been named new director of the center following a nationwide search.
Richard Amasino, Carlos O. Miller Professor of Biochemistry, studies plant development and biochemistry. (WARF Named)
The Cluster Hiring Initiative aims to provide an alternative to departmentally based hiring practices and norms.
Chang’s lab recently developed a stem-cell-based model that can be used to better understand the underlying mechanisms behind the Rett syndrome and screen new drugs as potential therapeutics.
NF1 is a genetic disease caused by changes, or mutations, to a single gene in the human DNA library. Roughly one out of 3,000 babies born in the United States have the disease. Sussman is among the interdisciplinary researchers looking for answers.
Thank you to all again for another successful Epigenetics Symposium earlier this fall! As a reminder of all of the great resources we have here on …
Qiang Chang, associate professor in the University of Wisconsin–Madison departments of Medical Genetics and Neurology, and associate director of the Waisman Intellectual and Developmental Disabilities Research Center is one of the finalists.
In the study, Wei Xu and her colleagues found that CARM1 protein modifies a cell metabolism protein, PKM2, and changes its function.
David Jarrard and Bing Yang won a WARF Innovation Award for their work predicting prostate cancer in tissue biopsies.